#Novavax company code
#Novavax company trial

Those mRNA vaccines deliver a genetic code to the body that instructs it to make its own spike protein, which trains the immune system to recognize and fight the famous spike protein that allows the SARS-CoV-2 virus to bind to cells and infect someone. Novavax is different than COVID-19 vaccines like Pfizer-BioNtech and Moderna. The Montreal facility is a first step toward being self-sufficient in a time of crisis and 'being able to hit the ground running and be prepared if anything like this were to occur again,' Chakrabarti said. And because future pandemics are a real possibility, having the ability to produce vaccines domestically would make Canada more independent. manufacturers, according to Chakrabarti.Ī domestic facility would ease, if not eliminate, those problems, he said. Once vaccines were approved by Health Canada, deliveries were slowed by supply-chain issues in Europe and political red tape with U.S. Novavax has filed for approval of its COVID-19 vaccine with Health Canada.

#Novavax company trial

WATCH | This is the first Canadian facility to produce a COVID-19 vaccine:Ī vial of the Phase 3 Novavax COVID-19 vaccine is seen ready for use in a clinical trial in London, England. Once it is up and running, federal officials say the facility should be able to produce 24 million doses of vaccine per year. Sumon Chakrabarti, an infectious diseases specialist at Trillium Health Partners in Mississauga.Ĭanadian production should start in 2022 at the National Research Council of Canada's Biologics Manufacturing Centre in Montreal.

'Having that type of effective vaccine within our borders is going to really allow us to roll this out to the population in a way that can take a bite out of the numbers,' said Dr.

biotech company of the same name, Novavax is known as a protein subunit vaccine, making it different from the current COVID-19 vaccines we know. The bottom line: It still requires two doses, but trials have shown it is highly effective and quicker to manufacture. It is a step that should help keep Canadians vaccinated through this current pandemic, equip the country for the next global health crisis and boost the nation's research and development.ĭeveloped by the U.S. Novavax files for COVID-19 vaccine approval in Canada.